[January 18, 2013]

Research and Markets: Pharmaceutical Industry in the United States - 2013 Report

Research and Markets (http://www.researchandmarkets.com/research/j2383j/pharmaceutical) has announced the addition of the "Pharmaceutical Industry in the United States" report to their offering.

Over the past decade, pharmaceutical companies have pushed the scientific envelope, working at the cellular and molecular levels to dramatically advance the treatment of disease.

Between 1995 and 2005, more than 300 new drugs, biologics, and vaccines that prevent and treat over 150 conditions were approved by the FDA.3 The FDA also gave the go-ahead for numerous new indications for previously approved medicines, allowing physicians to tailor treatment strategies to meet a patient's individual disease status, past medication history, side effect tolerance, and preferences.

The US pharmaceutical industry is a highly globalized industry, dominated by multinational companies that engage in significant business activity in many countries and whose products are distributed and marketed worldwide. The industry has undergone dramatic structural changes over the past fewdecades, with the rise of the biotechnology sector, substantial growth in demand driven by demographics and substitution away from other therapeutic modalities such as surgery, and increased competition from globally active generic manufacturers.

The pharmaceutical industry is under mounting scrutiny because of rapidly increasing expenditures for drugs in the United States. Drug expenditures are now the fastest-growing component of health care costs, increasing at the rate of about 15 percent per year. They account for about eight percent of health care spending, and at their current rate of increase, they will soon surpass spending for physicians' services and, for many health maintenance organizations (HMOs), the costs of hospitalization.

Key Topics Covered:

A. Executive Summary

B. The Global Pharmaceutical Industry - A Brief Profile

C. TRIPS and the Global Pharmaceutical Industry

D. Offshoring in the Pharmaceutical Sector

E. Analyzing the Pharmaceutical Industry in the US

F. International Competition and Economic Trends in the US Pharma Industry

G. Key Trends in the Pharmaceutical Sector Supply (News - Alert) Chain

H. Overall Market Trends

I. Barriers and Challenges in the US Pharma Sector

J. Strategies for Market Entry

K. Analyzing the Industry through PEST Framework

L. Analyzing the Industry through Porter's Five Forces Business Strategy Framework

M. Research and Development

O. Patents in the US Pharmaceutical Industry

P. Impact of the Hatch-Waxman Act on the US Pharmaceutical Industry

Q. Analyzing the Role of the Federal Drug Agency

R. Government Proposals Affecting the US Pharma Industry

S. Industry Outlook

T. Leading Players

U. Appendix

V. Glossary of Terms

Companies Mentioned

• Pfizer
• GlaxoSmithKline
• Merck & Company
• AstraZeneca
• Amgen
• Eli Lilly & Company
• Johnson & Johnson
• Novartis
• Bristol Myers Squibb
• Wyeth

For more information visit http://www.researchandmarkets.com/research/j2383j/pharmaceutical

[ Back To Technology News's Homepage ]